Renal Replacement Therapy in Liver Disease

2018 ◽  
pp. 65-69
Author(s):  
Bogdana Sabina Zoica ◽  
Akash Deep
Keyword(s):  
Liver Disease ◽  
Renal Replacement Therapy ◽  
Replacement Therapy

PWE-084 Itu escalation and renal replacement therapy in decompensated liver disease – utility or futility

Gut ◽  
2015 ◽  
Vol 64 (Suppl 1) ◽  
pp. A248.2-A249
Author(s):  
A Zahid ◽  
M Choudhury ◽  
B Eross ◽  
E Williams ◽  
N White ◽  
...  
Keyword(s):  
Liver Disease ◽  
Renal Replacement Therapy ◽  
Replacement Therapy ◽  
Decompensated Liver Disease

scholarly journals Comparative effectiveness of liver transplant strategies for end-stage liver disease patients on renal replacement therapy

2014 ◽  
Vol 20 (9) ◽  
pp. 1034-1044 ◽  
Author(s):  
Yaojen Chang ◽  
Lorenzo Gallon ◽  
Colleen Jay ◽  
Kirti Shetty ◽  
Bing Ho ◽  
...  
Keyword(s):  
Liver Disease ◽  
Renal Replacement Therapy ◽  
Liver Transplant ◽  
Replacement Therapy ◽  
Comparative Effectiveness ◽  
End Stage Liver Disease ◽  
End Stage

Renal Replacement Therapy in End-Stage Renal Disease Patients with Chronic Liver Disease and Ascites: Role of Peritoneal Dialysis

2008 ◽  
Vol 28 (2) ◽  
pp. 113-117 ◽  
Author(s):  
Kunal Chaudhary ◽  
Ramesh Khanna
Keyword(s):  
Liver Disease ◽  
Renal Replacement Therapy ◽  
Renal Disease ◽  
Replacement Therapy ◽  
Chronic Liver Disease ◽  
End Stage Renal Disease ◽  
Chronic Liver ◽  
Risk Of Bleeding ◽  
Stage Renal Disease ◽  
End Stage

Chronic liver disease and cirrhosis account for several thousand deaths in the United States and often these patients have renal disease that progresses to end-stage renal disease (ESRD), necessitating renal replacement therapy. These patients provide significant challenges to their physicians, especially in the management of their ESRD with dialysis. ESRD patients with chronic liver disease and ascites are more difficult to manage on hemodialysis (HD) due to their hemodynamic status and risk of bleeding. Peritoneal dialysis (PD) offers them a viable alternative, along with a stable hemodynamic status and a lower risk of bleeding. The overall morbidity and mortality as well as the risk of peritonitis appear to be almost similar between cirrhotic and non-cirrhotic PD patients. In the absence of clinical trials comparing HD versus PD in such a population, and despite the limited clinical observations, the authors support PD as a viable and effective form of renal replacement therapy for patients with ESRD and associated chronic liver disease with cirrhosis and ascites.

34 OUTCOME OF RENAL REPLACEMENT THERAPY IN PATIENTS WITH SEVERE LIVER DISEASE

2012 ◽  
Vol 2 (1) ◽  
pp. S21
Author(s):  
G Chawla ◽  
J Ramachandran ◽  
A Mohapatra ◽  
G Basu ◽  
UZ Zachariah ◽  
...  
Keyword(s):  
Liver Disease ◽  
Renal Replacement Therapy ◽  
Replacement Therapy ◽  
Severe Liver ◽  
Severe Liver Disease
Sign in / Sign up

Export Citation Format

Share Document